Processes for the production of thienopyrimidine derivatives
View Patent ↗The present invention provides a process for producing an intermediate for thienopyrimidine derivatives having the GnRH antagonistic activity at an industrial large scale. The process for production of the present invention relates to a process for producing a compound represented by the formula (III): wherein respective symbols have the same meanings as those described below, or a salt thereof, which comprises subjecting a compound represented by the formula (I): wherein R 1 denotes hydrogen, nitro, halogen, phthalimido, mono- or di-(alkylcarbonyl)amino or alkoxy, or a salt thereof, to an acid halogenating reaction, which is successively reacted with malonic acid ester and magnesium alkoxide, treated with an acid, and reacted with sulfur and a compound represented by the formula: NCCH 2 COOR 2 [wherein R 2 denotes alkyl or aryl], or a salt thereof, in the presence of primary amine. According to the process of production of the present invention, thienopyrimidine derivatives having the GnRH antagonistic activity can be produced effectively and at an industrial large scale by a high yield and simple method.
1. A process for producing a compound represented by the formula(XII):
wherein respective symbols have the same meanings as those described below, which comprises:
subjecting a compound represented by the formula(I a ):
wherein R 1a denotes nitro, phthalimido, mono(alkylcarbonyl)amino or di(alkylcarbonyl)amino, or a salt thereof, to an acid halogenating reaction, which is successively reacted with malonic acid ester and magnesium alkoxide and, thereafter, treated with an acid and, then, reacted with a sulfur and a compound represented by the formula(II):
wherein R 2 denotes alkyl or aryl, or a salt thereof in the presence of primary amine, to obtain a compound represented by the formula (III):
wherein respective symbols have the same meanings as those described above, or a salt thereof and, then, reacting the compound (III) or a salt thereof with a compound represented by the formula(IV):
O═C═N—R 3 (IV)
wherein R 3 denotes alkyl optionally having a substituent or aryl optionally having a substituent, or a salt thereof, to obtain a compound represented by the formula (V):
wherein respective symbols have the same meanings as those described above, or a salt thereof and, then, subjecting the compound (V) or a salt thereof to a ring closing reaction, which is reacted with a compound represented by the formula(VI):
wherein R 4 denotes a leaving group, and R 5 denotes aryl optionally having a substituent, or a salt thereof, to obtain a compound represented by the formula (VII):
wherein respective symbols have the same meanings as those described above, or a salt thereof and, then, subjecting the compound (VII) or a salt thereof to a brominating reaction, which is successively reacted with a compound represented by the formula (VIII):
wherein R 6 and R 7 denote alkyl optionally having a substituent, aryl optionally having a substituent, alkoxy optionally having a substitutent, aralkyl optionally having a substituent or a heterocycle group optionally having a substituent, or a salt thereof, to obtain a compound represented by the formula (IX):
wherein respective symbols have the same meanings as those described above, or a salt thereof, and
(1) when R 1a is nitro, subjecting the compound (IX) or a salt thereof to a reducing reaction,
(2) when R 1a is phthalimido, subjecting the compound (IX) or a salt thereof to a deprotecting reaction, or
(3) when R 1a is mono(alkylcarbonyl)amino or di(alkylcarbonyl)amino, subjecting the compound (IX) or a or a salt thereof to a hydrolyzing reaction,
to obtain a compound represented by the formula (X):
wherein respective symbols have the same meanings as those described above, or a salt thereof and, then,
(i) reacting the compound (X) or a salt thereof, with halogenoformic acid ester and a compound represented by the formula (XI):
wherein R 8 and R 9 denote a hydrogen atom, alkoxy optionally having a substituent or alkyl optionally having a substituent, or a salt thereof, or
(ii) reacting the compound (X) or a salt thereof with carbonyldiimidazole and a compound represented by the formula (XI):
wherein respective symbols have the same meanings as those described above or a salt thereof.
2. The process according to claim 1 , wherein R 1a is nitro.
3. The process according to claim 1 , wherein R 3 is phenyl optionally having a substituent.
4. The process according to claim 1 , wherein R 5 is phenyl optionally having a substituent.
5. The process according to claim 1 , wherein one of R 6 and R 7 is C 1-3 alkyl, and the other of them is benzyl optionally having a substituent.
6. The process according to claim 1 , wherein one of R 8 and R 9 is a hydrogen atom, and the other of them is C 1-3 alkoxy.
7. The process according to claim 1 , wherein the compound (VII) or a salt thereof is subjected to a brominating reaction in the presence of bromine and a radical initiator.
8. A process for producing a compound represented by the formula(III):
wherein respective symbols have the same meanings as those described below, or a salt thereof, which comprises:
subjecting a compound represented by the formula
wherein R 1 denotes a hydrogen atom, nitro, halogen, phthalimido, mono(alkylcarbonyl)amino, di(alkylcarbonyl)amino or alkoxy, or a salt thereof, to an acid halogenating reaction, which is successively reacted with malonic acid ester and magnesium alkoxide and, thereafter, treated with an acid and, then, reacted with sulfur and a compound represented by the formula (II):
wherein R 2 denotes alkyl or aryl, or a salt thereof, in the presence of primary amine.
9. The process according to claim 1 , wherein R 1 is nitro.
10. The process according to claim 1 , wherein the primary amine is mono-C 3-8 alkylamine.